TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · major macro event coming up
SLGL

Sol Gel Technologies Ltd

Healthcare · Biotechnology

72.30$ +4.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement SLGL
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– – – 172.4% 21,818.6% 177.2% 318.2% 65.2% 326.6% 22.0% 2.0% 0.6%
– – – -72.4% -21,718.6% -77.2% 100.0% 34.8% -226.6% 100.0% 100.0% 100.0%
– – – 14,830.5% 21,818.6% 177.2% 318.2% 65.2% 326.6% 1,514.9% 154.3% 117.6%
– – – 3,449.4% 4,266.7% 36.1% 126.5% 27.0% 191.7% 474.5% 49.8% 21.5%
– – – 18,279.9% 26,085.3% 213.3% 444.7% 25.3% 191.7% 1,985.8% 204.1% 138.9%
– – – -18,179.9% -25,985.3% 113.3% -344.7% 9.5% -418.3% -1,885.8% -104.1% -38.9%
– – – 0.0% 0.0% 6.0% 0.0% 2.8% 34.0% – – –
– – – -18,142.5% -24,963.6% -107.3% -333.9% 10.3% -384.3% -1,752.8% -91.7% -31.6%
– – – -37.4% -1,021.7% 0.1% -21.5% -3.6% -34.0% 0.0% – –
– – – -18,142.5% -24,963.6% -107.4% -312.4% 10.3% -384.3% -1,752.8% -91.7% -31.6%
– – – -17,909.2% -25,394.6% -109.4% -333.9% 12.3% -403.9% -1,863.8% -102.1% -38.3%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?